GP120 immunogens and methods inducing neutralizing antibodies to human immunodeficiency virus
US10092638B2 · kind B2 · utility
0Cited by
9References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 3, 2012 |
| Grant date | Oct 9, 2018 |
| Priority date | — |
| Expiry date | Oct 3, 2032 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates, in general, to an HIV-1 vaccine and, in particular, to a B cell lineage-based vaccination protocol.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.